In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a simple sequence of words, but as a complex web of non-linear relationships.

A decade ago, the NFL’s “Next Gen” journey started with hardware. The league embedded RFID chips into every player’s shoulder ...

Unlike traditional testing, which requires hundreds or thousands of charge – discharge cycles, the model can estimate a new ...

At Web Summit Qatar, AI-powered biotech startups describe how automation, data, and gene editing are filling labor gaps in ...

A large-scale analysis of millions of cancer studies has uncovered patterns suggesting that a significant portion of the literature may not be as reliable as it appears.

It’s no longer about hiring specialists. The market now demands hybrid marketers: people who can speak to both business goals ...

The government is asking experts and academics to help shape a plan to tackle the growing issue of deepfakes, ITV News ...

The degradation is subtle but cumulative. Tools that release frequent updates while training on datasets polluted with ...

Evolving toxicity assessments for engineered nanoparticles underline the importance of predictive models and life-cycle risk ...

AI empowers solopreneurs Gabriela Fiorentino, Clara Ma, and Lis Best to enhance community support by reducing operational load.

The conversational prowess of AI chatbots like ChatGPT, Gemini, and Claude appears to stem from sophisticated algorithms alone, but this apparent autonomy masks a critical dependency: after these AI ...